ArticleScientific reports2026
QSPR analysis of the drugs used to treat renal failure and its complications using degree and modified reverse degree indices.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- QSPR analysis of the drugs used to treat major depressive disorder using degree and neighborhood degree based indices.Frontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
QSPR plays a crucial role in drug design by predicting the biological activity and the physico-chemical properties of compounds based on their molecular structures. The indices based on topology are important in QSPR analysis that serve as numerical descriptors that capture structural features of molecules, enabling accurate property prediction without extensive experimental work. Renal failure and its complications are marked by progressive loss of kidney function and systemic effects, often leading to complex management challenges and increased morbidity and mortality. This research study concentrates on the structural characteristics of medications used for treating renal failure and its complications, including sotagliflozin, vadadustat, empagliflozin, canagliflozin, daprodustat, calcitriol, pravastatin, pitavastatin, paricalcitol, dapagliflozin, finerenone, cinacalcet, irbesartan, captopril, doxercalciferol, epoetin alfa, hydrochlorothiazide, tenapanor, and etelcalcetide. We have done QSPR analysis incorporating degree and modified reverse degree indices and performed a comparison to demonstrate our models’ efficacy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.